OAC
NERV icon

OMERS Administration Corp’s Minerva Neurosciences NERV Stock Holding History

OMERS Administration Corp’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,300
Closed -$62.1K – 1063
2026
Q1 		$62.1K Buy
+10,300
New +$59.1K ﹤0.01% 1053

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OMERS Administration Corp's NERV Position: Q2 2026 in Review

OMERS Administration Corp sold out of Minerva Neurosciences (NERV) in Q2 2026, closing a stake of 10,300 shares — an estimated $62.1K sold.

OMERS Administration Corp first reported a position in NERV in Q1 2026 and held it in 1 quarter. The position peaked at $62.1K in Q1 2026. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • OMERS Administration Corp reported no remaining Minerva Neurosciences position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 10,300 Minerva Neurosciences shares in Q2 2026, an estimated $62.1K.
  • OMERS Administration Corp first reported a position in Minerva Neurosciences in Q1 2026 and held it in 1 quarter.
  • OMERS Administration Corp's Minerva Neurosciences position peaked at $62.1K in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.